LiverMultiScan™ analysis of UK Biobank indicates as many as 1 in 8 adults may have non-alcoholic steatohepatitis (NASH)

Perspectum Diagnostics today revealed new data which indicates that the prevalence of non-alcoholic steatohepatitis (NASH) among UK adults could be as high as …

LiverMultiScan™ Receives FDA 510(k) Clearance for Version 2 of Medical Device

We are delighted to announce that LiverMultiScan™ has received FDA 510(k) clearance for the next release of the software. Read the full press release below: …

LITMUS Project – LiverMultiScan™ included in ground-breaking €34 million project to develop better test for liver disease

A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify thos…